BB Biotech AG - CE with IsEquityFund

NEW
XSWX:BION (Switzerland)   CE with IsEquityFundamentalDataAvailable = 1 in Gid
CHF 47.6 -0.20 (-0.42%) Jun 26
3.27
P/B:
1.00
Market Cap:
CHF 2.63B ($ 3.30B)
Enterprise V:
CHF 2.27B ($ 2.85B)
Volume:
76.09K
Avg Vol (2M):
77.19K
Trade In:

GF Valueâ„¢

BB Biotech AG’s share price is CHF47.6. Its GF Value is CHF0. Based on the relationship between the current stock price and the GF Value, GuruFocus believes BB Biotech AG stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: CHF47.6 GF Value Price/GF Value
Current CHF0 Infinity
Next FY1 End CHF0 Infinity
Next 12 Month CHF0 Infinity
Next FY2 End CHF0 Infinity
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing BB Biotech AG's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between BB Biotech AG's stock price and Book Value per share, with a coefficient of 94%. BB Biotech AG’s stock price shows no significant correlation with Revenue per share. BB Biotech AG’s stock price shows no significant correlation with Earnings without NRI per share. BB Biotech AG’s stock price shows no significant correlation with Operating Cash Flow per share.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies